BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2468948)

  • 1. L-649,923: an antagonist of cardiac and vascular leukotriene D4 receptors.
    Sirén AL; Eimerl J; Feuerstein G
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):210-7. PubMed ID: 2468948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    Sirén AL; Feuerstein G
    J Pharmacol Exp Ther; 1988 Oct; 247(1):69-78. PubMed ID: 2459371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and regional hemodynamic effects of leukotrienes D4 and E4 in the conscious rat.
    Eimerl J; Sirén AL; Feuerstein G
    Am J Physiol; 1986 Oct; 251(4 Pt 2):H700-9. PubMed ID: 3021000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.
    Hahn RA; MacDonald BR; Morgan E; Potts BD; Parli CJ; Rinkema LE; Whitesitt CA; Marshall WS
    J Pharmacol Exp Ther; 1992 Mar; 260(3):979-89. PubMed ID: 1312172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primate myocardial and systemic hemodynamic responses to leukotriene D4: antagonism by LY171883.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1987 Jul; 242(1):62-9. PubMed ID: 3612538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic cholinergic and beta-adrenergic contribution to hindquarters vasodilation and cardiac responses to cocaine.
    Knuepfer MM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):515-22. PubMed ID: 12730277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
    Smith EF; Slivjak MJ; Eckardt RD; Newton JF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of leukotriene (LT) D4 and a LTD4 receptor antagonist in the pig.
    Zellner JL; Cook JA; Reines DH; Wise WC; Smith EF; Kessler LD; Halushka PV
    Eicosanoids; 1990; 3(4):219-24. PubMed ID: 1963540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential hemodynamic effects of leukotriene D4 in anesthetized rats: evaluation by directional pulsed Doppler technique.
    Bayorh MA; Faden AI; Feuerstein G
    Prostaglandins Leukot Med; 1985 Feb; 17(2):229-41. PubMed ID: 3856895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353.
    Smith EF; Kinter LB; Jugus M; Eckardt RD; Newton JF
    Eicosanoids; 1989; 2(2):101-7. PubMed ID: 2560662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure.
    Roca-Cusachs A; DiPette DJ; Nickols GA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):110-8. PubMed ID: 1988652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of leukotrienes C4, D4 and E4 in the canine renal and mesenteric vascular beds.
    Feigen LP
    J Pharmacol Exp Ther; 1983 Jun; 225(3):682-7. PubMed ID: 6306215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene D4 and hypoxia: differential effects on the pulmonary and systemic circulations in newborn piglets.
    Bradley LM; Feuerstein G; Goldstein RE; Czaja JF
    Eicosanoids; 1989; 2(1):15-20. PubMed ID: 2633795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs.
    Fiedler VB; Mardin M; Abram TS
    Basic Res Cardiol; 1987; 82(2):197-208. PubMed ID: 3606544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the leukotriene receptor antagonist LY-171883 on endotoxemia in awake sheep.
    Krausz MM; Dahan JB; Gross D
    Circ Shock; 1988 Dec; 26(4):431-41. PubMed ID: 2850874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular responses to leukotriene C4 in the rat.
    Iacopino VJ; Fitzpatrick TM; Ramwell PW; Rose JC; Kot PA
    J Pharmacol Exp Ther; 1983 Oct; 227(1):244-7. PubMed ID: 6620169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized cardiovascular and regional hemodynamic effects of meperidine in conscious dogs.
    Priano LL; Vatner SF
    Anesth Analg; 1981 Sep; 60(9):649-54. PubMed ID: 7196709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.